Hepatocellular carcinoma with main portal vein tumor thrombus: Treatment with 3-dimensional fConformal radiotherapy after portal vein stenting and transarterial chemoembolization

Cancer

Volumn 115, Issue 6, 2009, Pages 1245-1252

  Zhang, Xue Bin ^a   Wang, Jian Hua ^a   Yan, Zhi Pin ^a   Qian, Sheng ^a   Du, Shi Suo ^a   Zeng, Zhao Chong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Carcinoma; Hepatocellular; Interventional; Portal vein tumor thrombus; Radiology; Radiotherapy; Stent

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; MALE; PERCUTANEOUS TRANSHEPATIC PORTAL VEIN STENTING; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; STENT; SURVIVAL RATE; THREE DIMENSIONAL IMAGING; TREATMENT RESPONSE; VASCULAR TUMOR;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PALLIATIVE CARE; PORTAL VEIN; RADIOTHERAPY, CONFORMAL; STENTS; SURVIVAL ANALYSIS; VASCULAR PATENCY; VENOUS THROMBOSIS;

EID: 63449142282     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24139     Document Type: Article

References (30)

1. Minagawa M, Makuuchi M. Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol. 2006;12:7561-7567.
2. Niguma T, Mimura T, Tutui N. Adjuvant arterial infusion chemotherapy after resection of hepatocellular carcinoma with portal thrombosis: a pilot study. J Hepatobiliary Pan- creat Surg. 2005;12:249-253.
3. Takizawa D, Kakizaki S, Sohara N, et al. Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis. Dig Dis Sci. 2007;52:3290-3295.
4. Lee HS, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer. 1997;79:2087-2094.
5. Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 1985;56:918-928.
6. Yeung YP, Lo CM, Liu CL, Wong BC, Fan ST, Wong J. Natural history of untreated nonsurgical hepatocellular carcinoma. Am J Gastroenterol. 2005;100:1995-2004.
7. Kulik LM, Carr BI, Mulcahy MF, et al. Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology. 2008;47: 71-81.
8. Fan J, Wu ZQ, Tang ZY, et al. Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein. World J Gastroenterol. 2001;7:28-32.
9. Tazawa J, Maeda M, Sakai Y, et al. Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement. J Gastroenterol Hepatol. 2001;16:660-665.
10. Lin CS, Jen YM, Chiu SY, et al. Treatment of portal vein tumor thrombosis of hepatoma patients with either stereo- tactic radiotherapy or three-dimensional conformal radiotherapy. Jpn J Clin Oncol. 2006;36:212-217.
11. Tsukamoto T, Hirohashi K, Kubo S, et al. Percutaneous transhepatic metallic stent placement for malignant portal vein stenosis. Hepatogastroenterology. 2003;50:453-455.
12. Yamakado K, Nakatsuka A, Tanaka N, Fujii A, Terada N, Takeda K. Malignant portal venous obstructions treated by stent placement: significant factors affecting patency. J Vasc Interv Radiol. 2001;12:1407-1415.
13. Higaki I, Hirohashi K, Kubo S, et al. Portal vein stenting to treat portal vein tumor thrombus in hepatocellular carcinoma. Osaka City Med J. 2000;46:99-104.
14. Yamakado K, Tanaka N, Nakatsuka A, Matsumura K, Takase K, Takeda K. Clinical efficacy of portal vein stent placement in patients with hepatocellular carcinoma invading the main portal vein. J Hepatol. 1999;30:660-668.
15. Ishii S, Sato M, Sonomura T, Yamada K, Tanihata H, Ishikawa H, et al. Optimal covering material for stent-grafts placed in the portal vein in a canine model. Cardiovasc Intervent Radiol. 2005;28:624-631.
16. Li B, Yu J, Wang L, et al. Study Of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma. Am J Clin Oncol. 2003;26:e92-e99.
17. Dawson LA, Guha C. Hepatocellular carcinoma: radiation therapy. Cancer J. 2008;14:111-116.
18. Sugiyama S, Beppu T, Ishiko T, et al. Efficacy of radiotherapy for PV and IVC tumor thrombosis in unresectable HCC. Hepatogastroenterology. 2007;54:1779-1782.
19. Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer. 1980;45:2220-2224.
20. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid Tumors. J Natl Cancer Inst. 2000;92:205-216.
21. Kita K, Ebara M, Yoshikawa M, Sugiura N, Ohto M. [Prognostic factors of hepatocellular carcinomas after non- surgical treatment]. Gan To Kagaku Ryoho. 1995;22:977-982.
22. Kiely JM, Rilling WS, Touzios JG, et al. Chemoembolization in patients at high risk: results and complications. J Vasc Interv Radiol. 2006;17:47-53.
23. Jeon SH, Park KS, Kim YH, et al. [Incidence and risk factors of acute hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma]. Korean J Gastroenterol. 2007;50:176-182.
24. Kishi K, Mitsuzane K, Sonomura T, Nishida N, Sato M, Yamada R. Dacron-covered stent therapy for portal vein tumor thrombus in hepatocellular carcinoma. Acta Radiol. 1993;34:266-269.
25. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359:1734-1739.
26. Ishikura S, Ogino T, Furuse J, et al. Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Clin Oncol. 2002;25:189-193.
27. Kim TH, Kim DY, Park JW, et al. Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable. Am J Clin Oncol. 2006;29:568-575.
28. Liu MT, Li SH, Chu TC, et al. Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization. Jpn J Clin Oncol. 2004;34:532-539.
29. Yamakado K, Nakatsuka A, Tanaka N, et al. Portal venous stent placement in patients with pancreatic and biliary neoplasms invading portal veins and causing portal hypertension: initial experience. Radiology. 2001;220:150-156.
30. Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378-390.